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Abstract
Hepatitis C virus (HCV) is remarkable for its ability to establish persistent infection. Studies suggest that HCV core protein modulates
immune responses to viral infection and can bind Fas receptor in vitro. To further examine the role of HCV core protein in Fas signaling,
full-length (aa 1-192) and truncated (aa 1-152) HCV core proteins were expressed in Jurkat lymphocytes and cells were assayed for
apoptotic response, caspase activation, and Fas activation. Jurkat expressing full-length but not truncated core protein exhibited ligand-
independent apoptosis. Cytoplasmic targeting of truncated core protein recapitulated its ability to induce apoptosis. Activation of caspases
8 and 3 was necessary and sufficient for full-length core to induce apoptosis. Jurkat cells expressing full-length but not truncated core protein
induced Fas receptor aggregation. HCV core activates apoptotic pathways in Jurkat via Fas and requires cytoplasmic localization of core.
Infection of host lymphocytes by HCV may alter apoptotic signaling and skew host responses to acute infection.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Hepatitis C virus (HCV) is the major cause of infectious
hepatitis in the U.S. and is epidemic worldwide (Alter,
1996). Infection with HCV leads to a high incidence of
persistent infection and progression to chronic hepatitis.
Multiple mechanisms for how this virus can apparently
evade the host immune response to establish a persistent
infection have been suggested (Moorman et al., 2001).
Based on the limited studies available, however, HCV may
have a modulatory effect on the immune system. Recent
studies suggest, for example, that patients with chronic
HCV infection have enhanced peripheral T cell apoptosis
(Toubi et al., 2001). Such immunomodulatory effects could
contribute to viral persistence and autoimmunity.
HCV contains a single-strand, 9.5-kb positive-sense
RNA genome that encodes three structural proteins (core
protein, E1, and E2) and at least six nonstructural proteins
(Choo et al., 1991). Of these proteins, HCV core protein has
been shown to have immunomodulatory functions (Large et
al., 1999; Moorman et al., 2001). When core protein was
expressed in mice via vaccinia virus or Sindbis virus, it led
to reduced cytotoxic T cell (CTL) activity and decreased
production of IL-2 and IFN- (Large et al., 1999). Ray et al.
demonstrated that core protein represses NFB activation,
with genomic variation in HCV determining the functional
regulation of this transcription factor (Ray et al., 2002).
Other studies have not found an immunomodulatory role for
core protein (Giannini et al., 2002; Liu et al., 2002; Sun et
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al., 2001), and additional studies are necessary. HCV core
protein has, however, been shown to interact in vitro with
several key transmembrane receptors involved in immunity,
including TNFR1 and Fas (Hahn et al., 2000; Zhu et al.,
1998).
Fas is a member of the tumor necrosis family of receptors
(TNFR) and plays a key role in immune regulation through
activation-induced T cell death (Ashkenazi and Dixit,
1998). Fas triggers cell death through its cytoplasmic do-
main following receptor engagement with Fas ligand
(FasL). The binding of FasL to Fas induces receptor trim-
erization and ultimately receptor multimerization. This
leads to recruitment and activation of a cascade of proteases
and ultimately to cell death.
The components of this caspase cascade have been
well-delineated (Martin et al., 1998; Nagata and Golstein,
1995). FADD appears to be the first molecule recruited to
the cytoplasmic death domain of the Fas receptor. This in
turn recruits caspase 8 via a death effector domain inter-
action that activates the protease and initiates proteolytic
activation of the multiple downstream effectors of
caspase 8, including caspase 3. Activation of these down-
stream proteases induces cleavage of death substrates
such as ICAD that ultimately lead to nuclear breakdown
and apoptosis.
We have recently demonstrated that transient expression
of HCV core protein leads to a sensitization of Jurkat cells
to FasL-induced apoptosis (Hahn et al., 2000). In that study,
we identified an in vitro molecular interaction between
HCV core protein and the cytoplasmic domain of Fas. Other
investigators have also shown in vitro molecular interac-
tions of HCV core with other TNFR family members (Ma-
tsumoto et al., 1997; Zhu et al., 1998), as well as enhance-
ment of FADD-mediated apoptosis in response to HCV core
protein expression (Zhu et al., 2001).
In this current study, we have employed a transient
expression system based on Sindbis virus to permit effi-
cient delivery of full-length and truncated core proteins
to lymphocytes. We have more fully characterized the
effect of HCV core expression on the Fas signaling path-
way and demonstrated that HCV core expression induces
ligand-independent apoptosis in Jurkat cells. We show
that expression of full-length HCV core leads to activa-
tion of caspase 3 and caspase 8 at the distal and proximal
aspects of the caspase cascade, respectively, and that this
activation is necessary and sufficient for apoptotic cell
death. We also demonstrate that expression of HCV core,
which we have previously shown to interact with Fas at
the molecular level, also induces Fas multimerization at
the cellular level as a means of activating the apoptotic
pathway. Finally, we show that this apoptosis and Fas
multimerization occurs upon expression of full-length
HCV core protein but not with expression of C-
terminally truncated core protein.
Results
Expression of full-length HCV core protein induces
ligand-independent apoptosis
Evidence from our previous studies suggested an HCV
core-Fas interaction in vitro. To determine the mechanism
of increased apoptosis in relation to this core-Fas interac-
tion, we employed a viral expression system based on Sind-
bis virus to facilitate high levels of expression of exogenous
core protein. Double subgenomic Sindbis recombinant virus
(dsSIN) capable of expressing full-length HCV core
(dsSIN:core192) and truncated HCV core (dsSIN:core152)
were generated. As a control virus, a Sindbis virus that
encodes an irrelevant protein, chloramphenicol acetyltrans-
ferase (dsSIN:CAT), was employed. This system has been
extensively used by our laboratories (Moorman et al., 1996,
1999).
Jurkat lymphocytes were infected with dsSIN:CAT or
dsSIN:core recombinants. HCV core expression was de-
tected in Jurkat at 24 h by immunoblotting (Fig. 1A). In-
fected Jurkat were assayed for apoptotic cells based on
DNA content by flow cytometry following propidium io-
dide staining. A significant increase in apoptotic cells at
24 h in Jurkat cells expressing full-length core protein
(48%) was observed that was not present in cells mock-
infected (3%) or dsSIN:CAT (4%) (Fig. 1B). Cells express-
ing truncated core protein by infection with dsSIN:core152
Fig. 1. (A) Expression of HCV core proteins in Jurkat lymphocytes. Cells
were infected with dsSIN expressing CAT (Lane 1), core152 (Lane 2), or
core192 (Lane 3). Lysates were resolved on SDS–PAGE and immunoblot-
ted with antibody to HCV core. (B) Ligand-independent induction of
apoptosis by HCV core. Jurkat cells were either mock-infected (mock) or
infected with dsSIN:CAT (CAT), dsSIN:core152 (Core152), or dsSIN:
core192 (Core192). Cells were incubated for 24 h (left bar of each pair) or
48 h (right bar of each pair), harvested, stained with propidium iodide, and
analyzed by flow cytometry. Apoptosis percentages were determined by
quantifying the 2 N nuclear content as described (Moorman et al., 1996).
Results represent the average of three independent experiments.
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did not induce apoptosis above the control cells at this time
point, but by 48 h had significant levels of apoptosis (28%)
above the control, CAT-expressing cells (6%).
Notably, no apoptosis was observed in the cells express-
ing full-length core proteins until approximately 18 h
postinfection, at which point rapid increases in apoptotic
cells were consistently observed. Morphological changes
indicative of apoptosis were noted in core-expressing cells
but not in CAT-expressing cells by light microscopy as well
(data not shown).
To confirm the proapoptotic role of HCV core protein,
stable transfectant Jurkat cell lines were developed that
were capable of expressing full-length core protein under
the control of a steroid-inducible promoter system. Upon
induction of HCV core expression using ponasterone A,
significant levels of apoptosis were detected in those cell
lines expressing HCV core but not in control transfectant
lines (data not shown). These levels were comparable to
those observed upon expression of HCV core by dsSIN.
HCV core-induced apoptosis is caspase 3 and 8
dependent
To examine whether the increased apoptosis of core-
expressing lymphocytes occurred via the conventional Fas-
mediated pathway, we examined the activation of and ne-
cessity for specific caspases involved in this pathway.
Caspase 3 is a downstream, effector caspase that is activated
in response to ligand-mediated Fas signaling, among others.
Caspase 8 is an upstream, initiator caspase that is known to
be activated by ligand binding of Fas and TNFR1. Full-
length HCV core protein was expressed in Jurkat and cells
were harvested at 24 h for measurement of caspase 3 (Fig.
2A) and caspase 8 (Fig. 2B) activities by detection of the
cleavage of colorimetric substrates of these caspases. Ex-
pression of HCV core induced significant activation of both
caspase 3 and caspase 8 in these assays that was not ob-
served in dsSIN:CAT-infected Jurkat.
If caspases 8 and 3 are indeed necessary for HCV core-
induced apoptotic signaling, then the inhibition of these
specific pathways would be expected to inhibit the apoptosis
that occurs following expression of HCV core protein. The
ability of HCV core to induce apoptosis was assayed in the
presence of specific, cell-permeable peptide inhibitors of
caspase 3 and caspase 8 in Jurkat. Inhibition of caspase 3
using Ac-DEVD-CHO, its specific peptide inhibitor, dra-
matically inhibited HCV core-induced apoptosis at 24 h
(Fig. 2C). Similarly, inhibition of caspase 8 using Ac-IETD-
CHO as a specific inhibitor also inhibited core-induced
apoptosis (Fig. 2D). Interestingly, this inhibition occurred if
inhibitors were added at any time prior to 18 h, when
apoptosis can first be detected in our assay (data not shown).
These data demonstrate that expression of HCV core medi-
ates apoptotic signaling that is dependent on both caspase 8
and caspase 3.
Membrane association of truncated core is sufficient for
induction of apoptosis
Expression of the truncated core protein, core152, was
consistently and significantly less able to induce apoptosis
in our assays. Subcellular localization studies have demon-
strated a nuclear localization for this form of core (Suzuki et
al., 1995), and it was thus possible that the inability to attain
sufficient levels of core protein at the transmembrane re-
ceptor site might explain this phenomena. If this is indeed
the case, then recapitulation of the ability of core152 to reach
the membrane compartment should restore its ability to
induce apoptosis.
To address the requirement of membrane association, we
engineered a dsSIN recombinant containing the truncated
core sequence fused with a C-terminal CAAX box sequence
derived from cdc42, a small GTPase (core152:CAAX). Such
a CAAX box is known to provide membrane localization to
proteins via lipid modification of the protein, but does not
induce apoptosis per se (Adamson et al., 1992; Moorman et
al., 1999). Expression of a GFP fusion proteins of core152,
core152:CAAX, and core192 in BHK confirmed a nuclear
localization of truncated core152 protein and cytoplasmic
localization of core152:CAAX and full-length core192 pro-
teins (Fig. 3). Jurkat cells were mock-infected or infected
with dsSIN:CAT, dsSIN:core152, and dsSIN:core152:CAAX
and core proteins were detected by immunoblotting (data
not shown). As shown in Fig. 4, expression of core152:
CAAX protein significantly increased the level of apoptosis
occurring in Jurkat cells at 24 and 48 h when compared to
expression of truncated core alone. We have previously
documented that other CAAX-containing proteins, includ-
ing cdc42, do not induce apoptosis in Jurkat (Moorman et
al., 1999).
Expression of full-length HCV core protein induces Fas
multimerization
Upon Fas activation by its natural ligand, multimeriza-
tion of Fas trimeric receptor complexes occurs and leads to
recruitment of FADD and, ultimately, activation of the
caspase cascade. Previous studies have documented the
spontaneous aggregation of Fas receptor in lymphocytes
upon treatment with UV light, leading to caspase activation
(Rehemtulla et al., 1997). To examine if HCV core might
similarly induce Fas multimerization, we employed an im-
munoprecipitation protocol using chemical crosslinking and
limiting antibody conditions that would preferentially im-
munoprecipitate oligomerized receptor (Rehemtulla et al.,
1997). Under limiting antibody concentrations, there was
increased immunoprecipitation of Fas due to receptor mul-
timerization in cells expressing full-length HCV core pro-
tein compared to CAT-expressing cells (Fig. 5A). This was
not seen under conditions of antibody excess, in which Fas
was reliably immunoprecipitated from all samples. Expres-
sion of truncated HCV core152, which could not induce
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Fig. 2. HCV core-induced apoptosis is caspase 3 and 8 dependent. (A) Caspase 3 activity in HCV core-expressing cells. Jurkat cells were subjected to mock
infection (mock) or infection with dsSIN:CAT (CAT) or dsSIN:core192 (Core192). Cells were incubated in RPMI for 24 h, harvested, lysed, and assayed for
caspase 3 activity using a calorimetric substrate of caspase 3, Ac-DEVD-pNA; plates were read at 405 nm. (B) Caspase 8 activity in HCV core-expressing
cells. Jurkat cells were subjected to infection as above. dsSIN:core192-infected Jurkat were additionally treated with Ac-IETD-Cho, a cell-permeable inhibitor
of caspase 8 (Core192  IETD). Cells were incubated, harvested, lysed as above, and assayed for caspase 8 activity using a calorimetric substrate of caspase
8, Ac-IETD-pNA. Caspase 8 (10 u) was used as an assay control. (C) Inhibition of core-mediated apoptosis by caspase 3 inhibitors. Jurkat cells were
mock-infected (Mock) or infected with dsSIN:CAT (CAT) or dsSIN:core192 alone (Core192) or with the addition of 100 M Ac-DEVD-CHO (Core192 
DEVD). Cells were analyzed for the presence of apoptosis using flow cytometry as described. (D) Dose-dependent inhibition of core-mediated apoptosis by
caspase 8 inhibitors. Jurkat cells were mock-infected (Mock) or infected with dsSIN:CAT (CAT), dsSIN:core192 alone (Core192), or with specific
concentrations of Ac-IETD-CHO (Core192  100 M, 50 M, 25 M, and 12.5 M IETD). Cells were analyzed for apoptosis by flow cytometry as
described. All results represent the average of at least three independent experiments.
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apoptosis at 24 h, also did not lead to increased immuno-
precipitation of Fas under limiting conditions (Fig. 5B).
These data suggest that the C-terminal portion of HCV core
is necessary for the Fas oligomerization that leads to apo-
ptosis.
Indirect immunofluorescent experiments using antibod-
ies to Fas were also employed to confirm receptor multi-
merization, as previously described (Rehemtulla et al.,
1997). Jurkat cells expressing either CAT or HCV core
proteins were fixed, incubated with a FITC-conjugated an-
tibody directed against Fas, and observed by fluorescent
microscopy using a confocal microscope (Fig. 6). Unin-
fected cells (not shown) and cells infected with control virus
(dsSIN:CAT), or virus expressing truncated HCV core152
(dsSIN:core152), demonstrated a heterogeneous cellular
staining pattern. Cells infected with dsSIN:core192, how-
ever, exhibited enhanced, brightly staining peripheral ag-
gregates. This pattern was identical to that observed in our
Jurkat cells treated with UV irradiation (data not shown),
which has been shown to induce Fas multimerization and
activation of its signaling pathway (Rehemtulla et al.,
1997). Overall levels of Fas expression were equivalent by
flow cytometry (data not shown).
Discussion
The Fas receptor plays a critical role in regulating T cell
homeostasis (Krammer, 2000). Previous studies have dem-
Fig. 3. Subcellular localization of core proteins. BHK were transfected with
plasmids expressing GFP (A), GFP:core152 (B), GFP:core192 (C), or GFP:
core152:CAAX (D). Cells were incubated for 24 h, fixed in 4% parafor-
maldehyde, and viewed using a Leica confocal fluorescent microscope with
a 60 objective.
Fig. 6. Multimerization of Fas receptor upon expression of full--
length HCV core by immunofluorescent staining of Fas. Jurkat
cells were infected with either dsSIN:CAT (A), dsSIN:core152 (B), or
dsSIN:core192 (C), incubated for 24 h, and fixed with 4% paraformal-
dehyde prior to staining for immunofluorescence using an FITC--
conjugated, Fas-specific antibody. Cells were viewed and photo-
graphed using a Leica confocal fluorescent microscope with a 60
objective.
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onstrated that HCV core protein can bind this receptor at its
cytoplasmic domain and enhance the sensitivity of several
cell lines to Fas-mediated apoptosis (Hahn et al., 2000;
Ruggieri et al., 1997). T lymphocytes from transgenic mice
expressing core protein under the control of a CD2 promoter
also have increased apoptosis in the presence of anti-Fas
antibody (Soguero et al., 2002), suggesting a sensitization
of these lymphocytes to Fas-mediated death signaling. Fur-
thermore, clinical studies of chronically infected patients
have demonstrated enhanced Fas-mediated apoptosis of
PBMCs using anti-Fas antibody (Taya et al., 2000). These
studies prompted a more thorough dissection of Fas signal-
ing pathways in the setting of core expression.
In this article, we have employed a transient expression
system based on Sindbis virus to permit efficient and coor-
dinated expression of HCV core protein in Jurkat lympho-
cytes to characterize the potential mechanism by which
HCV core mediates T cell suppression. We demonstrate
apoptotic cell death of lymphocytes in the presence of
full-length HCV core protein that is not seen in the presence
of control virus expression and that is not dependent on the
use of Fas ligand or anti-Fas antibodies. The data suggest,
however, that the apoptotic cell death induced by HCV core
is dependent on membrane localization of HCV core, in that
expression of C-terminal truncated core proteins (that are
known to have a nuclear localization) do not lead to apo-
ptotic signaling at comparable time intervals. This would be
consistent with the hypothesis that HCV core might bind the
cytoplasmic domain of Fas at the membrane to modulate its
signaling.
In our studies, expression of HCV core activates both
caspase 3, at the distal aspect of the caspase cascade, as well
as caspase 8 at the proximal aspect. Inhibition of these
caspases using specific tetrapeptide inhibitors demonstrates
that activation of these caspases by HCV core protein is
both necessary and sufficient for the observed apoptosis.
Furthermore, we show by both immunoprecipitation
techniques and fluorescent microscopy that HCV core pro-
tein induces Fas receptor multimerization proximal to the
caspase cascade. In light of our previous studies showing an
interaction between Fas and HCV core protein, the data
suggest that this interaction induces Fas receptor multimer-
ization and in doing so recruits the components necessary
for activation of the caspase cascade, ultimately leading to
apoptotic cell death.
Fas is a member of the TNFR family of receptors that as
a family may be particularly targeted by HCV core proteins.
Studies have suggested that HCV core can interact with
Fig. 4. Induction of apoptosis by membrane targeting of HCV core152.
Jurkat were mock-infected (Mock) or infected with dsSIN:CAT (CAT),
dsSIN:core152 (Core152), or dsSIN:core152:CAAX (Core152:CAAX).
Cells were collected at 24 h, lysed, and analyzed for apoptosis as described
above.
Fig. 5. Multimerization of Fas receptor upon expression of full-length HCV
core by limiting antibody immunoprecipitation. (A) Full-length HCV core
protein induces Fas multimerization. Jurkat cells were infected with either
dsSIN:CAT (Lanes 1 and 3) or dsSIN:core192 (Lanes 2 and 4) for 24 h,
treated with the crosslinking agent 3,3-dithiobis[sulfosuccinimidyl propi-
onate], and lysed for immunoprecipitation using polyclonal antibody to Fas
under antibody limiting conditions (Lanes 1 and 2) or antibody excess
conditions (Lanes 3 and 4). Immunoblotting of the immunoprecipitate was
performed using a Fas-specific mouse monoclonal antibody. (B) Truncated
HCV core152 does not induce Fas multimerization. Jurkat cells were in-
fected with dsSIN:CAT (Lane 1) or dsSIN:Core152 (Lane 2), harvested at
24 h, crosslinked, lysed, and immunoprecipitated under limiting antibody
conditions as above.
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LTR as well as TNFR1 (Matsumoto et al., 1997; Zhu et
al., 1998). Conflicting data regarding the effect of core
expression on TNFR1 signaling have emerged, although
recent investigations have demonstrated an interaction of
HCV core with FADD (Zhu et al., 2001). FADD is distal to
the transmembrane receptors Fas and TNFR1, and similar to
Fas, contains a death domain region. Those studies con-
cluded that the apoptosis observed upon core expression
was dependent on the FADD pathway rather than on a
TNFR1/HCV core interaction.
Our studies support this concept but would conclude that
the activation of this FADD pathway is the result of mul-
timerization of Fas proximal to FADD. Fluorescent micros-
copy data revealed a staining pattern identical to that ob-
served in cells treated with UV light, which has been shown
to induce Fas receptor multimerization (Rehemtulla et al.,
1997). We cannot at this juncture rule out that both mul-
timerization of Fas and binding/activation of FADD is oc-
curring. Additional support for a direct Fas-mediated induc-
tion of apoptosis arises from studies in hep2G liver cells in
which HCV core expression sensitized these cells to
apoptosis in the presence of anti-Fas antibody (Ruggieri et
al., 1997).
We can at this point only speculate on the mechanism by
which HCV core might induce multimerization of Fas. Core
protein can interact with itself in vitro and in vivo and forms
multimers at an early stage of viral assembly (Matsumoto et
al., 1996), with both membrane-bound and free forms of
core existing in dimeric and multimeric forms. Given that
HCV core interacts with Fas as well, such multimeric forms
of core could serve as links to induce Fas receptor proximity
and oligomerization. In such a model, one might expect that
even low levels of core expression might lead to an in-
creased susceptibility of infected cells to FasL or anti-Fas
antibody, as has been demonstrated (Hahn et al., 2000; Taya
et al., 2000). With enhanced levels of core expression that
can be achieved using Sindbis virus, apoptotic signaling
might be activated in the ligand-independent manner that
was observed in our study.
The necessity for full-length HCV core expression in
inducing Fas multimerization and apoptosis in our studies is
interesting and perhaps not unexpected. Expression of full-
length core in mammalian cells results in localization pri-
marily to the cytoplasm, apparently associated with mem-
branes (Barba et al., 1997; Santolini et al., 1994), whereas
C-terminal truncated proteins are rapidly localized to the
nucleus (Lo et al., 1995; Yasui et al., 1998). Since core
interacts with Fas at its cytoplasmic domain (Hahn et al.,
2000), a cytoplasmic localization for core would appear to
be required and has been shown to be necessary for mod-
ulating other intracellular signaling pathways such as NFB
(Watashi et al., 2001).
Interestingly, we consistently observed that lymphocytes
expressing truncated core proteins did not exhibit significant
apoptosis at 24 h but had some degree of apoptosis detect-
able at 48 h. While truncated core proteins are primarily
targeted to the nucleus, we did observe residual expression
in the cytoplasm following prolonged core expression in
immunofluorescent studies (J.P. Moorman, unpublished ob-
servations). It is feasible that cytoplasmic accumulation
over prolonged time intervals exceeds the threshold for Fas
activation.
The role of HCV core protein in immune suppression
and the pathogenesis of HCV infection has been subject to
debate. A generalized T cell suppression occurs during
human HCV infection, with a decreased CTL precursor
frequency in PBMCs of chronically infected patients (Re-
hermann et al., 1996b). Patients with chronic HCV infection
exhibit enhanced spontaneous and induced T cell apoptosis
that correlates with the severity of hepatic disease (Toubi et
al., 2001), and data from our murine model suggest that it is
the HCV core protein that not only suppresses CTC func-
tion, but also leads to diminished CTL precursors and in-
creased levels of virus replication (Large et al., 1999).
Liu et al., however, recently found no effect for core
protein on virus-specific immune responses using replica-
tion-deficient adenovirus vectors expressing core protein
(Liu et al., 2002), and Sun et al. examined C57BL/6 trans-
genic mice expressing core proteins and observed no inhi-
bition of antiviral responses (Sun et al., 2001). Similarly,
Giannini et al. found no effect on apoptotic pathways in B
cells stably expressing core protein (Giannini et al., 2002).
It should be noted, however, that the above studies were
performed using HCV core 1b proteins, whereas we have
employed HCV core 1a proteins in our experiments. Ray et
al. recently demonstrated a differential role for HCV core
proteins in immunomodulation, with genotype 1a core pro-
tein, but not core 1b protein, able to repress NFB activa-
tion (Ray et al., 2002). Discrepancies in studies examining
the immunosuppressive role of core protein may thus be
rooted in the genomic variation of core protein.
Although several reports indicated that HCV is able to
infect PBMC (Bronowicki et al., 1998; Cribier et al., 1995;
Zignego et al., 1992), replication of HCV in infected PBMC
has yet to be convincingly determined. Using a SCID mouse
model in which mice were inoculated with mononuclear
cells from HCV-infected subjects, Bronowicki et al. dem-
onstrated evidence of persistent HCV infection in these
mononuclear cells and a low rate of HCV replication
(Bronowicki et al., 1998). Other studies, however, have
failed to find clear evidence of viral replication in these cells
(Boisvert et al., 2001) and this issue remains controversial.
Based on our studies, it is feasible that infection of
lymphocyte populations during acute infection leads to a
susceptibility to Fas-mediated cell death, and ultimately, a
skewed or inadequate response to HCV infection. This
might permit impaired clearance of virally infected cell
populations, higher viral loads, and the greater viral diver-
sity that has been observed with higher viral loads (Farci et
al., 1997; Honda et al., 1994; Kanazawa et al., 1994).
Alternatively, apoptotic lymphocytes may be recruited to
the liver to induce hepatocyte damage via a bystander effect
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(Y.S. Hahn, unpublished observations). Protecting the func-
tion of lymphocytes during acute infection is likely to be
important, with studies suggesting that patients with strong
Th1 CD4 and more vigorous CTL responses have an
improved ability to clear this virus (Lechmann et al., 1996;
Nelson et al., 1997; Rehermann et al., 1996a).
The pathogenic mechanisms involved in HCV infection
remain complex and challenging to researchers. These stud-
ies support a role for the core protein of HCV in modulating
the normal immune responses to HCV infection and perhaps
facilitating immune evasion and viral persistence. Further
studies in infected human populations are ongoing.
Materials and methods
Cell culture and generation of dsSIN and GFP
recombinants
Jurkat cells were obtained from ATCC and maintained in
RPMI 1640 media supplemented with 10% (v/v) fetal bo-
vine serum and 2 mM glutamine. dsSIN capable of express-
ing CAT (designated dsSIN:CAT) have been previously
described (Moorman et al., 1996). dsSIN capable of ex-
pressing truncated core152 (designated dsSIN:core152) and
full-length core192 (designated dsSIN:core192) were gener-
ated from the plasmids pCIneo:core152 and pCIneo:core192
as previously described [genotype 1a core sequence] (Hahn
et al., 2000). Plasmids were digested with EcoR1/SalI and
the inserts placed into the plasmid pTE2J1 under the control
of a second subgenomic promoter of Sindbis virus. dsSIN:
core152 and dsSIN:core192 were generated by in vitro tran-
scription followed by transfection of infectious RNA into
BHK cells as described previously. Titers of Sindbis virus
recombinants were determined by plaque assay in BHK
cells, aliquoted, and stored at 70°C until use.
dsSIN capable of expressing the truncated core152 with a
CAAX box addition (designated dsSIN:core152:CAAX) was
generated as follows. Forward and reverse primers (5-
tctagaatgagcacgaatcctaa-3 and 5-agtcttatatgtcgtgaaggaaaa-
cccaactcaaaggcctccgcggtcccgggaccg-3, respectively) were
used to generate a PCR product using plasmid pCIneo:
core152 as a template. The resulting PCR product was di-
gested with Xba and subcloned in the plasmid PCR2.1 using
a TA cloning kit (Invitrogen, Carlsbad, CA). The plasmid
construct was confirmed by sequencing and digested with
Xba, and the insert was inserted into pTE2J1 under the
control of a second subgenomic promoter of Sindbis virus.
dsSIN:core152:CAAX was generated by in vitro transcrip-
tion followed by transfection of infectious RNA into BHK
cells as described previously. Titers of Sindbis virus recom-
binants were determined by plaque assay in BHK cells,
aliquoted, and stored at 70°C until use.
Plasmids expressing GFP were purchased from Invitro-
gen. Truncated, mutant, and full-length core protein se-
quences derived from the pCI:neo and pCR2.1 constructs
above were inserted distal to GFP using standard molecular
techniques.
dsSIN infections
Jurkat cells were harvested at a density of 5–7  105
cells/ml and resuspended in PBS containing divalent ions at
a concentration of 5  105 cells/ml. Appropriate viral in-
ocula were added and cells were incubated 1 h at 37°C for
viral absorption. Following absorption, prewarmed culture
media were added to a concentration of 5  105 cells/ml.
Fas crosslinking and immunoprecipitation
Jurkat cells (5  106) were subjected to mock infection
or infection with dsSIN:CAT, dsSIN:core152, or dsSIN:
core192. Cells were incubated 24 h, washed twice in PBS,
resuspended in 500 l of PBS, and treated with 2 mM
3,3-dithiobis[sulfosuccinimidyl propionate] (Pierce, Rock-
ford, IL) for 15 min on ice. The reaction was quenched with
10 mM ammonium acetate for 10 min. The cells were
pelleted and washed twice in PBS and lysed using 500 l of
lysis buffer containing 20 mM Tris (pH 7.4), 140 mM NaCl,
10% glycerol, 1% Triton X-100, and 2 mM EDTA in
addition to protease inhibitors. Lysates were used for im-
munoprecipitation in the presence of an anti-Fas antibody
(Apo-1, Kamiya Labs, Thousand Oaks, CA) at antibody-
limiting (0.5 g/ml) and antibody-excess (5 g/ml) concen-
trations. Immune complexes were immunoprecipitated us-
ing Protein A/G-Sepharose (Amersham Pharmacia Biotech,
Piscataway, NJ) and washed in lysis buffer three times. The
precipitate was resuspended in Laemmli loading buffer and
resolved on SDS–PAGE. Samples were transferred onto
Immobilon polyvinylidene difluoride (Millipore, Bedford,
MA) membranes in preparation for immunoblotting.
Immunoblotting
Jurkat were collected, washed with PBS, lysed in RIPA
buffer (50 mM Tris–Cl, pH 7.5, 150 mM NaCl, 1 mM
EGTA, 0.5% Nonidet P-40, 0.5% deoxycholate, 1 mM
4-(2-aminoethyl)-benzenesulfonyl fluoride, 0.3 M aproti-
nin, and 1 M leupeptin), and separated by 12% SDS-
PAGE. Proteins were transferred onto Immobilon mem-
branes. Membranes were blocked for 1 h in PBS containing
5% non-fat milk and 2% BSA and then immunoblotted
using antibody to hepatitis C core protein (ABR, Golden,
CO). Immunoreactive bands were detected using horserad-
ish peroxidase conjugated secondary antibodies in conjunc-
tion with an enhanced chemiluminescent system (Amer-
sham Pharmacia Biotech).
Fluorescent microscopy
Jurkat cells were subjected to mock infection or infection
with dsSIN recombinants, harvested at 24 h, washed in PBS,
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fixed in 4% paraformaldehyde for 20 min, and stained for
immunofluorescence with a fluorescein isothiocyanate con-
jugated anti-CD95/Fas antibody. Treated cells were
mounted on a coverslide and Fas-receptor immunostaining
was visualized and photographed using a Leica DMIRBE
confocal microscope with a 60 objective.
BHK on coverslips were transfected with plasmids
expressing GFP alone or GFP fusions with core proteins
using commercially available kits (Lipofectamine). Cells
were incubated for 24 h, washed in PBS, fixed in 4%
paraformaldehyde for 20 min, and mounted on cover
slides. Cells were visualized and photographed using a
Leica DMIRBE confocal microscope with a 60 objec-
tive.
Flow cytometric analysis of cellular DNA contents
DNA content was analyzed using flow cytometry as
described (Moorman et al., 1996). In brief, asynchronous
cultured Jurkat cells were subjected to infection with dsSIN
and harvested at 24 and/or 48 h. Cells were harvested,
washed in PBS, and resuspended in a staining solution
containing 50 g/ml propidium iodide, 0.3% NP-40, 100
g/ml boiled RNase, and 0.1% sodium citrate. Stained cells
were incubated at 4°C for at least 30 min and analyzed using
Becton-Dickinson FACSCaliber. Populations of cells con-
taining subdiploid DNA content were quantified according
to the DNA contents of the cell using Becton–Dickinson
Cell Quest software. An average of 104 cells was used in
each experiment.
Caspase assays
Caspase 3 and 8 activities were assayed using calorimet-
ric substrates of these caspases, Ac-DEVD-pNA or Ac-
IETD-pNA (Calbiochem, La Jolla, CA). Briefly, cells were
subjected to experimental conditions for 24 h and lysed in
RIPA buffer. Aliquots of lysate were added to 96-well
plates containing assay buffer provided in the kit and either
Ac-DEVD-pNA or Ac-IETD-pNA at 200 M with or with-
out inhibitors of the specific caspases, Ac-DEVD-CHO or
AC-IETD-CHO. Absorbance was read at 405 nm in a mi-
crotiter plate reader.
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